Patients With NSCLC Describe Experiences of Symptoms on Daily Life
September 12th 2023Patients with advanced or metastatic non–small cell lung cancer (NSCLC) were able to specify a 1-point threshold when describing meaningful symptom change, for better or worse, that helped illustrate their symptom experience.
Read More
What We’re Reading: Updated COVID-19 Vaccines; National Blood Shortages; Lack of Doctor Diversity
September 12th 2023FDA approves updated COVID-19 booster vaccines; low donor turnout and climate disasters result in a national blood shortage; minority patients discouraged by lack of doctor diversity.
Read More
Dr Andre Harvin: Specialty Pharmacists Are Integral to Oncology Care
September 10th 2023Specialty pharmacy is a big area of growth, with opportunity for patients, and specialty pharmacists can help payers and insurers ensure that patients get the full value of oncology medications, noted Andre Harvin, PharmD, MS, MBA, chief pharmacy officer, Oncology Services, Cone Health Cancer Centers.
Watch
TTFields Plus Paclitaxel Misses OS End Point in Platinum-Resistant Ovarian Cancer
September 9th 2023The phase 3 ENGOT-ov50/GOG-3029/INNOVATE-3 trial found the addition of tumor treating fields (TTFields) to paclitaxel did not provide a statistically significant improvement in overall survival (OS) vs paclitaxel alone for patients with platinum-resistant ovarian cancer, failing to meet its primary end point.
Read More
Local-Level Chronic Disease, Social Vulnerability Measures Help Inform COPD Planning Efforts
September 9th 2023The researchers demonstrated how to jointly examine prevalence estimates of chronic obstructive pulmonary disease (COPD) from PLACES and social vulnerability measures from the Social Vulnerability Index developed by the CDC and the Agency for Toxic Substances and Disease Registry.
Read More
Ponatinib Plus Chemotherapy Elicits MRD-Negative Remissions in Certain Patients With ALL
September 9th 2023Ponatinib also produces an improvement in progression-free survival compared with imatinib among those with Philadelphia chromosome-positive acute lymphoblastic leukemia in the phase 3 PhALLCON trial.
Read More
Condensed Proton Therapy Schedule Shows Promise for Patients With Breast Cancer
September 8th 2023New research suggests conventional fractionated and hypofractionated proton postmastectomy radiotherapy (PMRT) yield similar tolerability and complication rates for patients following mastectomy.
Read More
AML-Specific Early Mortality Risk Indices May Increase Accuracy of Care Quality Measurements
September 8th 2023A study found acute myeloid leukemia (AML) salvage therapy was independently associated with early mortality compared with frontline therapy, suggesting that algorithms measuring quality of care should incorporate risk mortality indices that factor in disease characteristics and treatment status.
Read More